Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Bosiers

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
Annals of Vascular Surgery|December 18, 2007
What we learned about trials from the European Carotid Stent TrialsClark J Zeebregts, Nick J Cheshire, Marc Bosiers, et al.
Surgical Technology International|October 12, 2017
AbsorbaSeal™ Vascular Closure Device: A Novel Device for Hemostasis Following Interventional Peripheral Vascular ProceduresEmily Benham, Koen Deloose, Joren Callaert, et al.
The Journal of Cardiovascular Surgery|October 22, 2014
Primary stenting is nowadays the gold standard treatment for TASC II A & B iliac lesions: the definitive MISAGO 1-year resultsKoen Deloose, Marc Bosiers, Joren Callaert, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 14, 2015
A single stent strategy in patients with lifestyle limiting claudication: 3-year results from the Durability II trialKrishna J Rocha-Singh, Marc Bosiers, Greg Schultz, et al.
Journal of Vascular Surgery|August 1, 2007
The type of embolic protection does not influence the outcome in carotid artery stentingVikram Iyer, Gianmarco de Donato, Koen Deloose, et al.
Annals of Vascular Surgery|March 4, 2015
24-Month Data from the BRAVISSIMO: A Large-Scale Prospective Registry on Iliac Stenting for TASC A & B and TASC C & D LesionsGianmarco de Donato, Marc Bosiers, Francesco Setacci, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|December 3, 2014
Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trialThomas Zeller, Patrick Peeters, Marc Bosiers, et al.
Annals of Vascular Surgery|April 22, 2018
Nine-Month Outcomes of the DURABILITY Iliac Study on Self-Expanding Stents for Symptomatic Peripheral Artery DiseasePeter Faries, Michael Jaff, Patrick Peeters, et al.
Journal of Vascular Surgery|May 4, 2016
Results from the Tack Optimized Balloon Angioplasty (TOBA) study demonstrate the benefits of minimal metal implants for dissection repair after angioplastyMarc Bosiers, Dierk Scheinert, Jeroen M H Hendriks, et al.
JACC. Cardiovascular Interventions|January 25, 2014
The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplastyDierk Scheinert, Stephan Duda, Thomas Zeller, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Annals of Vascular Surgery|December 18, 2007
What we learned about trials from the European Carotid Stent TrialsClark J Zeebregts, Nick J Cheshire, Marc Bosiers, et al.
Surgical Technology International|October 12, 2017
AbsorbaSeal™ Vascular Closure Device: A Novel Device for Hemostasis Following Interventional Peripheral Vascular ProceduresEmily Benham, Koen Deloose, Joren Callaert, et al.
The Journal of Cardiovascular Surgery|October 22, 2014
Primary stenting is nowadays the gold standard treatment for TASC II A & B iliac lesions: the definitive MISAGO 1-year resultsKoen Deloose, Marc Bosiers, Joren Callaert, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 14, 2015
A single stent strategy in patients with lifestyle limiting claudication: 3-year results from the Durability II trialKrishna J Rocha-Singh, Marc Bosiers, Greg Schultz, et al.
Journal of Vascular Surgery|August 1, 2007
The type of embolic protection does not influence the outcome in carotid artery stentingVikram Iyer, Gianmarco de Donato, Koen Deloose, et al.
Annals of Vascular Surgery|March 4, 2015
24-Month Data from the BRAVISSIMO: A Large-Scale Prospective Registry on Iliac Stenting for TASC A & B and TASC C & D LesionsGianmarco de Donato, Marc Bosiers, Francesco Setacci, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|December 3, 2014
Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trialThomas Zeller, Patrick Peeters, Marc Bosiers, et al.
Annals of Vascular Surgery|April 22, 2018
Nine-Month Outcomes of the DURABILITY Iliac Study on Self-Expanding Stents for Symptomatic Peripheral Artery DiseasePeter Faries, Michael Jaff, Patrick Peeters, et al.
Journal of Vascular Surgery|May 4, 2016
Results from the Tack Optimized Balloon Angioplasty (TOBA) study demonstrate the benefits of minimal metal implants for dissection repair after angioplastyMarc Bosiers, Dierk Scheinert, Jeroen M H Hendriks, et al.
JACC. Cardiovascular Interventions|January 25, 2014
The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplastyDierk Scheinert, Stephan Duda, Thomas Zeller, et al.
Pageof 10